Bristol-Myers Squibb

Bristol-Myers skin cancer drug Yervoy misses goal in study of additional, prostate cancer use
Yahoo/AP
Thu, 09/12/13 - 09:21 am
prostate cancer
Yervoy
Bristol-Myers Squibb
Novo Nordisk Pushes Ahead In Challenging Year
Investors.com
Tue, 09/10/13 - 04:48 pm
Novo Nordisk
Sanofi
Bristol-Myers Squibb
diabetes
Eli Lilly
MannKind
Pfizer Looks Good Despite Disappointing Eliquis Sales
Seeking Alpha
Fri, 09/6/13 - 08:20 am
Pfizer
Merck
Bristol-Myers Squibb
Eliquis
DVT
bloodthinners
Is 'No Worse Than Placebo' Good Enough For New Diabetes Drugs?
Forbes
Tue, 09/3/13 - 11:07 am
diabetes
saxagliptin
alogliptin
AstraZeneca
Bristol-Myers Squibb
Takeda
Bristol Myers: A Leader In Cancer Care
Seeking Alpha
Fri, 08/30/13 - 08:46 am
Bristol-Myers Squibb
Merck
Gilead
Pfizer
Roche
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
monoclonal antibodies
Roche
Herceptin
Rituxan
Avastin
GSK
Amgen
Eli Lilly
Bristol-Myers Squibb
Seattle Genetics
Adcetris
Kadcyla
bapineuzumab
Elan
JNJ
Pfizer
necitumumab
AbbVie
Humira
Vertex Building A Fortress In Cystic Fibrosis
Investopedia
Wed, 08/28/13 - 04:41 pm
Vertex
cystic fibrosis
Gilead
GSK
Kalydeco
Bristol-Myers Squibb
3 PDUFA Dates That Will Kick Off 2014
Motley Fool
Tue, 08/27/13 - 05:34 pm
FDA
diabetes
Forixga
Bristol-Myers Squibb
AstraZeneca
Biomarin
Vimizim
Amylin
metreleptin
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
FDA
breakthrough therapies
AbbVie
Alexion
Ariad Pharmaceuticals
Biomarin
Bristol-Myers Squibb
SynaGeva BioPharma
GSK
JNJ
Merck
Novartis
Pharmacyclics
Pfizer
Vertex Pharmaceuticals
daratumumab
ibrutinib
Kalydeco
lambrolizumab
palbociclib
LDK378
SD-101
obinutuzumab
serelaxin
asfotase alfa
bimagrumab
drisapersen
sebelipase alfa
Public Citizen petitions FDA for new warning about long-term use of Plavix in stent patients
Yahoo/AP
Wed, 08/21/13 - 10:11 am
FDA
Plavix
Public Citizen
Sanofi
Bristol-Myers Squibb
3 New Diabetes Drugs Possibly on the Way Soon
Motley Fool
Wed, 08/21/13 - 09:03 am
diabetes
Forixga
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Eli Lilly
Afrezza
MannKind
Cramer’s Bristol-Myers theorem: What is it? (video)
CNBC
Sat, 08/17/13 - 11:25 am
Bristol-Myers Squibb
A Chinese Checkered History for Big Pharma
Motley Fool
Fri, 08/16/13 - 10:40 am
China
GSK
Novo Nordisk
Bristol-Myers Squibb
Pfizer
Drug Manufacturers Industry: Where Bristol-Myers, Sanofi And Gilead Stand
Seeking Alpha
Wed, 08/14/13 - 09:23 pm
Sanofi
Bristol-Myers Squibb
Gilead
Albany Molecular says Bristol-Myers stops developing depression drug
Reuters
Mon, 08/12/13 - 05:01 pm
Albany Molecular Research
Bristol-Myers Squibb
BMS-820836
treatment-resistant depression
depression
Feds Probe Antipsychotic Prescriptions For Children In Medicaid
Pharmalot
Mon, 08/12/13 - 09:13 am
Medicaid
antipsychotics
Eli Lilly
Zyprexa
Bristol-Myers Squibb
Abilify
AstraZeneca’s
Seroquel
JNJ
Risperdal
Bristol-Myers Squibb's Earnings Made Easy
Motley Fool
Sun, 08/11/13 - 10:59 am
Bristol-Myers Squibb
earnings
3 Companies Working to Make Migraines Milder
Motley Fool
Wed, 08/7/13 - 09:36 am
migraines
Allergan
Botox
LY2951742
Eli Lilly
Arteaus Therapeutics
Merck
MK-1602
Alder Biopharmaceuticals
ALD403
Bristol-Myers Squibb
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Seeking Alpha
Tue, 08/6/13 - 10:00 am
GLP-1 agonist
diabetes
Oramed
Biodel
Bristol-Myers Squibb
Eli Lilly
MannKind
Novo Nordisk
Merck
Afrezza
Januvia
Victoza
These Pharmaceutical Giants Are Teetering Dangerously Near The Patent Cliff
Motley Fool
Sat, 08/3/13 - 10:16 am
Pfizer
Eli Lilly
Bristol-Myers Squibb
patent cliff

Pages